The stocks that performed poorly in 2023, like Li Ning, Meituan, Wuxi Biologics, and Zhongsheng, are showing a sharp rebound in the last month, with further potential gains from improving sentiment.
What is covered in the Full Insight:
Introduction
Overview of 2023 Performance
Detailed Analysis of Key Stocks
Future Prospects
Conclusion
Boomeranged on Fri, 27 Sep 2024 09:17
The "Dogs" surged more significantly than the HSI in the last two days. On average, their share price rose by 10.6%, outperforming the Index by 5.7pp. Instead, the widely overweighted names like China Unicom, CNOOC, and CLP Holdings have come down by an average of 4%. We believe the catch-up of the four names in this Insight will continue as interest reverts to those underperforming this year.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.